RIPK3 and neoplasm: In hepatocellular carcinoma (HCC) patients, increased RIPK1, RIPK3, and phosphorylated MLKL levels were positively correlated with increases in tumor-infiltrating CD3+ and CD8+ T-lymphocytes (65).